Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Eoganachton Aug 21, 2023 2:45pm
237 Views
Post# 35598373

RE:RE:Next week's trial result update

RE:RE:Next week's trial result updateI don't know FGPstock.

My guess would be that they don't have any serious bites from big pharma yet and I would attribute that to the fact that Theralase is breaking new ground. Big pharmas may be slow to change direction given all the money they have coming in with their current pipelines. How many anti-cancer photodynamic therapies is big pharma currently involved in?

I believe that at some point fantastic clinical data will overcome the risk of committing to new technology.

FGPstock wrote:

 

Ego, you definitely do your homework and add a lot of insight. But why do you feel Tlt would b in the middle of a pp if they were about to announce great numbers. Being the 21st, I am pretty sure they should already have the data in hand



<< Previous
Bullboard Posts
Next >>